• Every dose printed on the panel
  • Prices shown per serving
  • Cautions printed on the page
  • 30-day money-back guarantee
Which routine is right for you?See your routine

Research review

Does berberine help with GI disease? What the research does and doesn't show

Berberine's clearest human evidence for the gut is specific to diarrhea-predominant IBS, not GI disease broadly. Evidence for other conditions — IBD, SIBO, H. pylori — is much thinner.

By Electric Tiger Editorial

Berberine's clearest human evidence for the gut is specific to diarrhea-predominant IBS, not GI disease broadly. One randomized trial found symptom improvement at a dose closer to a typical supplement serving than most berberine research uses; evidence for other GI conditions — SIBO, inflammatory bowel disease, H. pylori — is much thinner.

What the evidence doesn't support

It doesn't support berberine as a treatment for GI disease broadly, or for any specific diagnosis — inflammatory bowel disease, SIBO, H. pylori infection — beyond diarrhea-predominant IBS, where one randomized trial exists. It also doesn't establish berberine as risk-free for the gut: its most consistently documented human side effects are gastrointestinal.

What the trials found

A 2015 randomized, double-blind, placebo-controlled trial gave 132 adults with diarrhea-predominant IBS either 400 mg of berberine hydrochloride a day (200 mg twice daily) or placebo for 8 weeks. The berberine group had significantly fewer episodes of diarrhea, abdominal pain and urgent bowel movements than placebo, along with a trend toward improved quality-of-life scores, and the treatment was well tolerated. At 400 mg a day, this trial used roughly 5.5 times our ~73 mg serving — closer than most berberine research, but still meaningfully more.

A separate, smaller phase I trial tested berberine's safety, not effectiveness, in 12 people with ulcerative colitis already on a prescribed medication, using 900 mg of berberine a day for three months. The trial's most notable finding was about safety: one of the 12 had a grade 3 liver-enzyme elevation during treatment, and one had grade 1 nausea. It's too small to draw a conclusion about inflammatory bowel disease from, but it's a caution, not a green light.

For SIBO and H. pylori — both conditions where berberine shows up in gut-health discussion — we didn't find a placebo-controlled human trial testing berberine on its own with a clear result to report here.

Questions people ask

Does berberine help with IBS?

One randomized trial found improvement in diarrhea-predominant IBS specifically, at 400 mg a day over 8 weeks — closer to typical supplement doses than most berberine research, though still above a 73 mg serving. It hasn't been tested in other IBS subtypes.

Does berberine cause diarrhea, or help with it?

Both, depending on dose and context. Berberine's most common documented side effect is GI upset, including diarrhea, especially at higher doses (34.5% of people in one trial at 1.5 g a day). Separately, a lower-dose trial (400 mg/day) in people who already had diarrhea-predominant IBS found it reduced diarrhea frequency. See does berberine cause diarrhea for the side-effect side of this.

When to talk to a doctor

Persistent GI symptoms, blood in stool, unexplained weight loss, or a diagnosed digestive condition are worth evaluating with a doctor rather than self-treating with a supplement. Berberine is not a treatment for IBS, IBD, SIBO or any diagnosed GI condition, and if you're on medication for one, talk to a doctor before adding berberine.

Related reading: does berberine cause diarrhea, does berberine affect the liver, and berberine side effects.

Sources

  1. A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome Phytotherapy research : PTR · 2015 · PMID 26400188A 2015 randomized, placebo-controlled trial in people with diarrhea-predominant IBS found 400 mg/day of berberine hydrochloride over 8 weeks significantly reduced diarrhea, abdominal pain and urgency compared with placebo, and was well tolerated.
  2. A Phase I Trial of Berberine in Chinese with Ulcerative Colitis Cancer prevention research (Philadelphia, Pa.) · 2020 · PMID 31619442A phase I safety trial in 12 people with ulcerative colitis given 900 mg/day of berberine for 3 months recorded one grade 3 liver-enzyme (transaminase) elevation as a possibly treatment-related adverse event, alongside one case of nausea.
  3. Efficacy of berberine in patients with type 2 diabetes mellitus Metabolism: clinical and experimental · 2008 · PMID 18442638In 36 adults, 1.5 g a day for three months had a blood-sugar effect comparable to metformin; about a third had stomach side effects.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.